Search alternatives:
point decrease » point increase (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
point decrease » point increase (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
-
17041
Table_2_Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study.docx
Published 2019“…Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.</p>Conclusion<p>Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. …”
-
17042
-
17043
-
17044
-
17045
-
17046
-
17047
Effects of forced Elf5 expression on tumor growth and cell autonomous pro-tumorigenic traits.
Published 2016“…Labels are EGFP- (G-), EGFP+ (G+) and WT (W). Raw data for panels E, F, G, and H can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002330#pbio.1002330.s001" target="_blank">S1 Data</a>.…”
-
17048
-
17049
DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx
Published 2024“…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
-
17050
DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx
Published 2024“…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
-
17051
-
17052
-
17053
-
17054
Protein thiols, GSH and GSSG levles in bone marrow cells.
Published 2014“…(<i>C)</i> Representative MALDI-MS images of GSH and GSSG in sectioned femur showing bone marrow distribution in WT and <i>Gstp1/p2</i><sup>−/−</sup> mice. …”
-
17055
-
17056
Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance
Published 2011“…We have presently clarified the signaling pathways leading to beta cell apoptosis following exposure to the viral mimetic double-stranded RNA (dsRNA) and a diabetogenic enterovirus (Coxsackievirus B5). …”
-
17057
Data_Sheet_1_NLRC5 Serves as a Pro-viral Factor During Influenza Virus Infection in Chicken Macrophages.docx
Published 2020“…In this study, we found that NLRC5 is activated by a range of low and highly pathogenic AIVs in primary chicken lung cells and a chicken macrophage cell line. …”
-
17058
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Published 2024“…<p>AZD1222 (ChAdOx1 nCoV-19) is a replication-deficient adenoviral vectored coronavirus disease-19 (COVID-19) vaccine that is manufactured as SII-ChAdOx1 nCoV-19 by the Serum Institute of India Pvt Ltd following technology transfer from Oxford University/AstraZeneca. …”
-
17059
-
17060